Literature DB >> 22544322

RUNX3 interactome reveals novel centrosomal targeting of RUNX family of transcription factors.

Linda Shyue Huey Chuang1, Soak Kuan Lai, Maki Murata-Hori, Ayumi Yamada, Hoi-Yeung Li, Jayantha Gunaratne, Yoshiaki Ito.   

Abstract

RUNX family proteins are critical regulators of lineage differentiation during development. The high prevalence of RUNX mutation/epigenetic inactivation in human cancer indicates a causative role for dysfunctional RUNX in carcinogenesis. This is supported by well-documented evidence of functional interaction of RUNX with components of major oncogenic or tumor suppressive signaling pathways such as TGFβ and Wnt. Here, we explore the binding partners of RUNX3 proteins to further define the scope of RUNX3 function. Using a mass spectrometry-based approach, we found that RUNX3 binds to centrosomal protein rootletin. This led us to uncover the presence of RUNX proteins at the centrosome. Our findings suggest a potential function for RUNX3 during mitosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22544322     DOI: 10.4161/cc.20278

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  9 in total

1.  Aurora kinase and RUNX: Reaching beyond transcription.

Authors:  Linda Shyue Huey Chuang; Vaidehi Krishnan; Yoshiaki Ito
Journal:  Cell Cycle       Date:  2016-08-05       Impact factor: 4.534

2.  Aurora kinase-induced phosphorylation excludes transcription factor RUNX from the chromatin to facilitate proper mitotic progression.

Authors:  Linda Shyue Huey Chuang; Jian Ming Khor; Soak Kuan Lai; Shubham Garg; Vaidehi Krishnan; Cheng-Gee Koh; Sang Hyun Lee; Yoshiaki Ito
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-23       Impact factor: 11.205

3.  RUNX2 is overexpressed in melanoma cells and mediates their migration and invasion.

Authors:  Rajeev K Boregowda; Oyenike O Olabisi; Walid Abushahba; Byeong-Seon Jeong; Keneshia K Haenssen; Wenjin Chen; Marina Chekmareva; Ahmed Lasfar; David J Foran; James S Goydos; Karine A Cohen-Solal
Journal:  Cancer Lett       Date:  2014-03-18       Impact factor: 8.679

4.  The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion.

Authors:  Mamadou Keita; Magdalena Bachvarova; Chantale Morin; Marie Plante; Jean Gregoire; Marie-Claude Renaud; Alexandra Sebastianelli; Xuan Bich Trinh; Dimcho Bachvarov
Journal:  Cell Cycle       Date:  2013-02-26       Impact factor: 4.534

5.  Core binding factor β (CBFβ) is retained in the midbody during cytokinesis.

Authors:  Cesar Lopez-Camacho; Andre J van Wijnen; Jane B Lian; Janet L Stein; Gary S Stein
Journal:  J Cell Physiol       Date:  2014-10       Impact factor: 6.384

6.  RUNX1 prevents oestrogen-mediated AXIN1 suppression and β-catenin activation in ER-positive breast cancer.

Authors:  Nyam-Osor Chimge; Gillian H Little; Sanjeev K Baniwal; Helty Adisetiyo; Ying Xie; Tian Zhang; Andie O'Laughlin; Zhi Y Liu; Peaches Ulrich; Anthony Martin; Paulette Mhawech-Fauceglia; Matthew J Ellis; Debu Tripathy; Susan Groshen; Chengyu Liang; Zhe Li; Dustin E Schones; Baruch Frenkel
Journal:  Nat Commun       Date:  2016-02-26       Impact factor: 14.919

Review 7.  Moonlighting in Mitosis: Analysis of the Mitotic Functions of Transcription and Splicing Factors.

Authors:  Maria Patrizia Somma; Evgeniya N Andreyeva; Gera A Pavlova; Claudia Pellacani; Elisabetta Bucciarelli; Julia V Popova; Silvia Bonaccorsi; Alexey V Pindyurin; Maurizio Gatti
Journal:  Cells       Date:  2020-06-26       Impact factor: 6.600

8.  NANOG/NANOGP8 Localizes at the Centrosome and is Spatiotemporally Associated with Centriole Maturation.

Authors:  Erika Mikulenkova; Jakub Neradil; Ondrej Vymazal; Jan Skoda; Renata Veselska
Journal:  Cells       Date:  2020-03-11       Impact factor: 6.600

9.  Evidence That Non-Syndromic Familial Tall Stature Has an Oligogenic Origin Including Ciliary Genes.

Authors:  Birgit Weiss; Birgit Eberle; Ralph Roeth; Christiaan de Bruin; Julian C Lui; Nagarajan Paramasivam; Katrin Hinderhofer; Hermine A van Duyvenvoorde; Jeffrey Baron; Jan M Wit; Gudrun A Rappold
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-04       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.